NextCure, Inc. (LS:A41AKJ) Financings

NextCure, Inc.

Financings

RaiseDate
Private placement of private placement concurrent with the Merger
Made bigger: about US$820M
Use of proceeds: To advance development of AVR-001 and support future operations of the combined company after the Merger.
Nov 10, 2026
Private placement of shares of common stock and pre-funded warrants
Closed: US$21.5M raised · US$8.52 a share · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Buyers: Ikarian Capital; Squadron Capital Management; Affinity Healthcare Fund, LP.; Exome Asset Management; Affinity Healthcare Fund, LP
Use of proceeds: General working capital, extending cash runway into first half of 2027, beyond first half 2026 proof of concept data readouts of SIM0505 and LNCB74
Nov 17, 2025

Read by 6ix AI from the company's releases